Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 9,133-9,144 of 23,847
Drug study icon
CompletedNCT01692782

Adult Attention Deficit Hyperactivity Disorder

This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

Multiple locations, including Encino
ADHDDrugA study involving a medication or substance.From 18 Years to 55 Years
Countries
United States
Sponsor
Sumitomo Pharma America, Inc.
Condition
ADHD
Drug study icon
CompletedNCT03659929

Adult Attention Deficit Hyperactivity Disorder (ADHD) Study With Amphetamine Sulfate

This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

Multiple locations, including Encino
ADHDDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Arbor Pharmaceuticals, Inc.
Condition
ADHD
Drug study icon
CompletedNCT00931723

Adult Bipolar Mania

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Montignies-sur-Sambre
BipolarityDrugFrom 18 Years to 65 Years
Countries
Belgium, Bulgaria, Germany, ...
Sponsor
AstraZeneca
Condition
Bipolarity
Behavioral study icon
CompletedNCT06915207

Adult Depression and Integrative Medical Care

This summary needs review. Please check the official study record and contact the research team for details.

In Saskatoon
DepressionBehavioralFrom 18 Years to 65 Years
Countries
Canada
Sponsor
University of Saskatchewan
Condition
Depression
Other study type icon
CompletedNCT01308450

Adult Normative Performance of the Quotient ADHD System

This study exists to understand what helps a digital app or remote support tool work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

In Clinton
ADHDOtherFrom 15 Years to 55 Years
Countries
United States
Sponsor
BioBehavioral Diagnostics Company
Condition
ADHD
Other study type icon
CompletedNCT01247610

Adult Outcome of Children With Attention-deficit/Hyperactivity Disorder

This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

In Taipei
ADHDOtherFrom 17 Years to 24 Years
Countries
Taiwan
Sponsor
National Taiwan University Hospital
Condition
ADHD
Drug study icon
CompletedNCT02577575

Adult Oxytocin Study

This summary needs review. Please check the official study record and contact the research team for details.

In San Francisco
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of California, San Francisco
Condition
Schizophrenia
Drug study icon
CompletedNCT02567032

Adult Study Oxytocin - Behavioral

This summary needs review. Please check the official study record and contact the research team for details.

In San Francisco
SchizophreniaDrugFrom 18 Years to 45 Years
Countries
United States
Sponsor
University of California, San Francisco
Condition
Schizophrenia
Drug study icon
CompletedNCT02566356

Adult Study Oxytocin - fMRI

This summary needs review. Please check the official study record and contact the research team for details.

In San Francisco
SchizophreniaDrugFrom 18 Years to 50 Years
Countries
United States
Sponsor
University of California, San Francisco
Condition
Schizophrenia
Other study type icon
CompletedEUCTR 2006-001529-24

Eszopiclone 3 mg Co-administered with Venlafaxine for Depression

This study is completed in France, in the United Kingdom, in Hungary, .... It is testing Eszopiclone 3 mg Co-administered with Venlafaxine for Depression.

In Hungary
DepressionOther
Countries
France, United Kingdom, Hungary, ...
Sponsor
Sepracor NV in care of Sepracor Inc.
Condition
Depression
Other study type icon
CompletedNCT01553695

Adults With Attention Deficit Hyperactivity Disorder (ADHD): Validation of a Clinical Interview and Screening Instruments in French

This study exists to see whether questionnaires and follow-up reports can make care clearer and more responsive. Researchers are trying to understand whether questionnaires and follow-up reports can give earlier or clearer feedback during care.

In Nice
ADHDOtherFrom 18 Years to 55 Years
Countries
France
Sponsor
Centre Hospitalier Universitaire de Nice
Condition
ADHD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.